Auricularia polytricha protein extract and anti-tumor application thereof
A technology of Auricularia pilosa protein and extract, which is applied in the direction of antineoplastic drugs, peptide/protein components, applications, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] Embodiment 1, the preparation of Auricularia officinalis protein extract
[0032] 1. Prepare the fruiting body of Auricularia auricula
[0033] Inoculate Auricularia polytricha (Mont.) Sacc. No. 3 slant strains into the first-level medium for activation, culture at a constant temperature of 25°C, and inoculate it into the second-level medium after the mycelium is full of the test tube in a constant temperature culture room at 25°C until the hyphae are overgrown, inoculate the second-grade species into a cultivation bag with a cultivation medium for growth at 25°C, and scratch the bacteria after the strain is full of the cultivation bag and transplant it into the In the greenhouse, the fruiting conditions should keep the humidity above 90% and the temperature at 20-25°C. Collect the first tide fruiting bodies to obtain No. 3 fruiting bodies of Auricularia polytricha (Mont.) Sacc.
[0034] Wherein, the culture medium used in this experiment is as follows:
[0035] Prima...
Embodiment 2
[0042] Example 2. Experiment of inhibiting tumor cell proliferation by Auricularia auricularia protein extract
[0043]1.1 Tested cell lines
[0044] Human liver cancer HepG2 cells (purchased from ATCC, USA), human breast cancer MCF-7 cells (purchased from ATCC, USA) and human lung adenocarcinoma A-549 cells (purchased from ATCC, USA).
[0045] 1.2 Experimental method
[0046] 1.2.1 Cell lines and cell culture
[0047] Human liver cancer HepG2 cells, human breast cancer MCF-7 cells and human lung adenocarcinoma A-549 cells were activated and passaged according to conventional culture methods. Among them, the subculture and activation medium of human liver cancer HepG2 cells is DMEM-high glucose + 1% double antibody + 10% FBS (in DMEM-high glucose (Hyclone, SH30022.01B) a mixture of penicillin and streptomycin (penicillin 10000U / mL, streptomycin 10000μg / mL) and fetal bovine serum (FBS, Hyclone, SV30087.02), so that the final volume percentage of the former two is 1%, and the...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com